NCT00316667

Brief Summary

The aim is to assess the population prevalence of risk factors for different chronic diseases such as cardiovascular disease, type 2 diabetes, osteoporosis, asthma, and allergy. Risk factors include genetic and serologic biomarkers, questionnaire data on health and lifestyle. There are many hypotheses under study for each research field.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
3,471

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2006

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 19, 2006

Completed
2 days until next milestone

First Posted

Study publicly available on registry

April 21, 2006

Completed
1 month until next milestone

Study Start

First participant enrolled

June 1, 2006

Completed
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2008

Completed
Last Updated

October 3, 2012

Status Verified

October 1, 2012

First QC Date

April 19, 2006

Last Update Submit

October 2, 2012

Conditions

Cardiovascular DiseaseType 2 DiabetesAsthmaHypersensitivityOsteoporosis

Keywords

epidemiologyrisk factors

Eligibility Criteria

Age18 Years - 69 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Random sample of citizens living in 11 municipalities in Copenhagen. Age 18-69 years.

You may qualify if:

  • Persons living in 11 municipalities in Copenhagen

You may not qualify if:

  • Pregnancy
  • Non-Danish citizenship

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Research Centre for Prevention and Health

Copenhagen, Glostrup, DK-2600, Denmark

Location

Related Publications (2)

  • Svendstrup M, Allin KH, Angquist L, Schnohr P, Jensen GB, Linneberg A, Thuesen B, Astrup A, Saris WHM, Vestergaard H, Sorensen TIA. Is abdominal obesity at baseline influencing weight changes in observational studies and during weight loss interventions? Am J Clin Nutr. 2018 Nov 1;108(5):913-921. doi: 10.1093/ajcn/nqy187.

    PMID: 30475965DERIVED

  • Ahluwalia TS, Troelsen JT, Balslev-Harder M, Bork-Jensen J, Thuesen BH, Cerqueira C, Linneberg A, Grarup N, Pedersen O, Hansen T, Dalgaard LT. Carriers of a VEGFA enhancer polymorphism selectively binding CHOP/DDIT3 are predisposed to increased circulating levels of thyroid-stimulating hormone. J Med Genet. 2017 Mar;54(3):166-175. doi: 10.1136/jmedgenet-2016-104084. Epub 2016 Sep 14.

    PMID: 27627987DERIVED

Biospecimen

Retention: SAMPLES WITH DNA

Extracted DNA, urine, serum

MeSH Terms

Conditions

Cardiovascular DiseasesDiabetes Mellitus, Type 2AsthmaHypersensitivityOsteoporosis

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesBronchial DiseasesRespiratory Tract DiseasesLung Diseases, ObstructiveLung DiseasesRespiratory HypersensitivityHypersensitivity, ImmediateImmune System DiseasesBone Diseases, MetabolicBone DiseasesMusculoskeletal Diseases

Study Officials

  • Allan Linneberg, MD, PhD

    Glostrup University Hospital, Copenhagen

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Manager

Study Record Dates

First Submitted

April 19, 2006

First Posted

April 21, 2006

Study Start

June 1, 2006

Study Completion

June 1, 2008

Last Updated

October 3, 2012

Record last verified: 2012-10

Locations

DK(1)